Bega Bionutrients is launching Inferrinâ„¢, a novel form of microencapsulated lactoferrin. The microencapsulation can help deliver the benefits of lactoferrin by protecting it from degradation in conditions found in the stomach. Inferrinâ„¢ opens up new benefits and applications for lactoferrin based products including foods and dietary supplements.
An initial pilot clinical trial on Inferrinâ„¢ has shown promising results. In a double-blind, randomised, controlled, cross-over trial in healthy males, InferrinTM demonstrated effects on immune markers and the gut microbiome. The study also showed higher levels of lactoferrin in the faecal matter in those consuming InferrinTM. This suggests InferrinTM is indeed surviving degradation in the stomach and influencing the gut microbiome. â€œWe are very excited by these results, and we are already planning to commence a larger scale clinical study later this year to follow up on these results.â€ said Dr Bradley Coleman, Business Manager of Bega Bionutrients.
â€œLactoferrin has been extensively studied and documented for its multiple health benefits in adults and infants. But as a protein, lactoferrin is at risk of being broken down in the mature stomach before it can reach the small intestine, where it is believed much of its activity takes place.â€ said Dr Coleman. â€œUnderstanding this issue, we worked with Australian encapsulation company Progel Pty Ltd and the University of Queensland to develop a form of lactoferrin that is protected through the stomach and released intact in the small intestine. Using Progelâ€™s novel and patented microencapsulation technology, we developed InferrinTM – lactoferrin microencapsulated in common food grade materials. InferrinTM will open new market opportunities for our customers and supports innovative product applicationsâ€.
InferrinTM is ideal for use in foods and dietary supplements. The unique microencapsulation technology allows InferrinTM to use in a wide variety of delivery formats including gels, powders and liquids, as well as the more traditional tablets and capsules.
â€œThe installation of the microencapsulation technology at Begaâ€™s Tatura Milk Industries facility in Victoria, Australia strengthens Begaâ€™s product development and production capabilities in specialty ingredients and life-stage nutritionals.â€
Bega Bionutrients will feature InferrinTM at Vitafoods on in Geneva this May.
In partnership with our North American distributor, STAUBER PERFORMANCE INGREDIENTS, Bega Bionutrients will be showcasing our products at SupplySideWest, in Las Vegas on October 6th and 7th.
â€œItâ€™s been an exciting year of expansion for us and weâ€™re looking forward to sharing our developments with customers at SupplySideWestâ€ commented Business Development Manager Bradley Coleman. â€œThe success weâ€™re having with our flagship lactoferrin product is due to the unique benefits our sourcing and processing methods have for customers. All our dairy bionutrients are sourced from fresh cowâ€™s milk thatâ€™s hormone and BSE free. The cows have a pasture based diet and live close â€“ over 80% are within 40 km [25 miles] of our plant. This makes a difference to quality, ensuring natural bionutrients with maximum bio-activity and clean labelling.â€
STAUBER, a leading provider of ingredients for nutraceutical, food, beverage, flavour, and pet industries, represents Bega Bionutrients in North America. Visit Bega Bionutrients and Stauber at SupplySideWest, booth# V115, Mandalay Bay, Las Vegas on October 6th and 7th.
Bega Bionutrients products are well suited for use in a range of applications including dietary supplements, functional foods, medical nutrition and cosmetics. To discuss your ingredient requirements, please contact us at firstname.lastname@example.org or for North American enquiries, please contact Stauber at email@example.com
Bega Bionutrients Lactoferrin, produced by Tatura Milk Industries Ltd, a wholly owned subsidiary of Bega Cheese Ltd, has been recently granted novel food status in Europe and is available for sale.
The decision of the authority assessing the application states: â€˜â€¦that the bovine lactoferrin produced by Tatura Milk Industries of Australia is substantially equivalent to bovine lactoferrin already authorised for the EU market with respect to composition, nutritional value, metabolism, intended use and level of undesirable substances.â€™
Matthieu Arguillere, General Manager Bionutrients added; â€˜Our lactoferrin is directly extracted from very fresh, premium quality Australian cowâ€™s milk using gentle methods that preserve the integrity and bioactivity of the protein. Our milk comes from some of the best dairying regions in Australia. Thanks to this high quality production, we have built up a substantial lactoferrin business over the past decade supplying customers throughout Asia and Oceania. This approval opens up a number of exciting new business opportunities in Europe and gives European customers a new source of well-established, high quality lactoferrin for their products.â€™
Lactoferrin is used in a number of food products, including infant nutrition, supplements and lifestyle nutrition products.
Bega Bionutrients is a manufacturer and supplier of specialty health and nutrition ingredients. Our aim is to improve the health and wellness of people through delivering innovative bionutrient products. Bega Bionutrients is a division of Bega Cheese Limited, one of Australiaâ€™s largest dairy companies, listed on the Australian Securities Exchange.